SPAC27D7.02c Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Mechanism

Antibodies are Y-shaped immunoglobulins composed of heavy and light chains, with antigen-binding (Fab) and effector (Fc) regions . If SPAC27D7.02c were characterized, its structure would typically include:

  • Heavy chains: Determining class (IgG, IgA, IgM) and subclass (e.g., IgG1, IgG4).

  • Light chains: κ or λ chains, critical for antigen specificity.

  • Epitope binding: Target antigen(s) and binding affinity (e.g., KD values).

ParameterHypothetical Example (If SPAC27D7.02c Were Characterized)
Antibody ClassIgG1
Light Chain Typeκ
Target AntigenHypothetical protein X
Binding Affinity10 nM (similar to high-affinity monoclonals)

Applications and Experimental Data

Antibodies are validated across techniques like flow cytometry, immunohistochemistry (IHC), and bioassays. For SPAC27D7.02c, typical experimental data might include:

  • Flow cytometry: Staining efficiency in cell lines (e.g., MCF-7) .

  • IHC: Localization in tissues (e.g., cytoplasmic or membrane staining) .

  • Neutralization assays: Inhibition of target protein function .

TechniqueExpected Outcome (If Data Were Available)Reference
Flow CytometrySpecificity in target cell line staining
ImmunohistochemistryTissue localization (e.g., squamous carcinoma)
NeutralizationIC50/EC50 for antigen binding

Market and Research Trends

The global antibody market reached $5.33 billion in 2027, driven by oncology and infectious disease research . If SPAC27D7.02c were commercialized, it might align with trends in:

  • Primary antibodies: Used for direct antigen detection .

  • Therapeutic antibodies: Engineered for neutralization (e.g., COVID-19 variant-targeting SC27) .

Market SegmentRelevance to SPAC27D7.02c
Primary AntibodiesCore detection reagent
Therapeutic UsePotential neutralization

Recommendations for Further Investigation

  1. Search Updated Databases: Check PubMed, CiteAb, or Biocompare for recent publications .

  2. Targeted Literature Reviews: Focus on studies involving similar antibody classes or epitopes .

  3. Contact Manufacturers: Suppliers like R&D Systems or Sino Biological may offer custom antibody development .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC27D7.02c antibody; GRIP and coiled-coil domain-containing protein C27D7.02c antibody
Target Names
SPAC27D7.02c
Uniprot No.

Target Background

Database Links
Subcellular Location
Cytoplasm.

Q&A

What is SPAC27D7.02c and why is it significant in Schizosaccharomyces pombe research?

SPAC27D7.02c is a GRIP domain-containing protein specific to Schizosaccharomyces pombe (fission yeast). The protein (UniProt accession O42657) plays a significant role in cellular function within this model organism. As a GRIP domain protein, it likely participates in Golgi trafficking and membrane organization, which are fundamental cellular processes conserved across eukaryotes. Studying this protein contributes to our understanding of membrane trafficking pathways in S. pombe and potentially provides insights into similar pathways in higher eukaryotes.

The significance of SPAC27D7.02c in S. pombe research stems from its specificity to this organism, making it valuable for studying species-specific adaptations in membrane organization and trafficking. While commercial antibodies are available for this protein (such as CSB-PA522111XA01SXV), researchers should carefully validate these reagents for their specific applications .

How should I validate the specificity of a SPAC27D7.02c antibody for experiments in S. pombe?

Validation of SPAC27D7.02c antibody specificity requires a multi-step approach:

  • Western blot analysis: Compare protein detection between wild-type and SPAC27D7.02c deletion strains. A specific antibody will show a band at the expected molecular weight in wild-type samples that is absent in deletion strains.

  • Immunoprecipitation followed by mass spectrometry: Perform IP experiments and analyze the precipitated proteins by mass spectrometry to confirm that SPAC27D7.02c is the predominant protein pulled down.

  • Epitope tagging validation: Create a strain with epitope-tagged SPAC27D7.02c (e.g., with HA or GFP) and perform parallel detection with both anti-tag and anti-SPAC27D7.02c antibodies to confirm co-localization.

  • Immunofluorescence specificity controls: Include negative controls (deletion strains) and positive controls (overexpression strains) when performing immunofluorescence to verify signal specificity.

  • Cross-reactivity assessment: Test the antibody against lysates from related yeasts (e.g., S. cerevisiae) to confirm the absence of cross-reactivity with similar proteins, as expected for a species-specific protein .

What are the optimal fixation and permeabilization methods for immunofluorescence detection of SPAC27D7.02c in S. pombe?

For optimal immunofluorescence detection of SPAC27D7.02c in S. pombe, consider the following protocol:

Fixation options:

  • 3.7% formaldehyde for 30 minutes at room temperature preserves most cellular structures

  • For Golgi proteins like SPAC27D7.02c (GRIP domain), a combination of 3% paraformaldehyde and 0.2% glutaraldehyde may provide better ultrastructural preservation

Permeabilization methods:

  • 1.2M sorbitol with 0.1% Triton X-100 for 5 minutes (gentler approach)

  • 70% ethanol for 30 minutes at -20°C (stronger permeabilization)

Critical considerations:

  • Test multiple fixation and permeabilization combinations, as GRIP domain proteins may be sensitive to certain fixatives

  • Include controls with known Golgi markers to verify proper preservation of Golgi structure

  • Compare results with live-cell imaging of fluorescently tagged SPAC27D7.02c to ensure fixation doesn't disrupt native localization

For detailed protocols on S. pombe immunostaining, researchers should adapt methods from established cell biology work while optimizing specifically for GRIP domain proteins.

How can I use the SPAC27D7.02c antibody to study protein interactions in S. pombe?

To study protein interactions of SPAC27D7.02c in S. pombe, several approaches can be employed:

Co-immunoprecipitation (Co-IP):

  • Prepare S. pombe cell lysates under non-denaturing conditions using gentle detergents (0.5-1% NP-40 or 0.5% Triton X-100)

  • Pre-clear lysates with Protein A/G beads

  • Incubate with SPAC27D7.02c antibody (typically 2-5 μg per 1 mg total protein)

  • Capture complexes with Protein A/G beads

  • Wash stringently to remove non-specific interactions

  • Elute bound proteins and analyze by Western blot or mass spectrometry

Proximity-based labeling:

  • Create S. pombe strains expressing SPAC27D7.02c fused to BioID or TurboID

  • Induce proximity labeling with biotin

  • Purify biotinylated proteins using streptavidin

  • Identify interacting proteins by mass spectrometry

  • Validate key interactions using SPAC27D7.02c antibody in reciprocal Co-IP experiments

Yeast two-hybrid screening:

  • Use SPAC27D7.02c as bait to screen for interacting partners

  • Validate positive interactions in vivo using SPAC27D7.02c antibody for Co-IP confirmation

When analyzing results, consider that GRIP domain proteins typically interact with Golgi-associated proteins and small GTPases. The BioGRID database contains information on protein interactions in S. pombe that may provide potential candidates for validation .

What are the common challenges in Western blot detection of SPAC27D7.02c and how can they be addressed?

Common challenges and their solutions for Western blot detection of SPAC27D7.02c include:

Challenge 1: Weak or no signal

  • Solution: Optimize protein extraction using specialized buffers containing stronger detergents (1-2% SDS) to ensure complete extraction of membrane-associated GRIP domain proteins

  • Increase antibody concentration (1:500 to 1:100 dilutions may be necessary)

  • Extend primary antibody incubation to overnight at 4°C

  • Use enhanced chemiluminescence (ECL) substrates with higher sensitivity

Challenge 2: Multiple bands or non-specific binding

  • Solution: Increase blocking stringency (5% BSA instead of 5% milk)

  • Add 0.1-0.5% Tween-20 to washing buffers

  • Perform antigen pre-absorption of the antibody

  • Use S. pombe SPAC27D7.02c deletion strain lysate as a negative control

Challenge 3: Inconsistent results between experiments

  • Solution: Standardize protein extraction protocols

  • Include loading controls specific for S. pombe (e.g., α-tubulin)

  • Consider using PVDF membranes instead of nitrocellulose for better protein retention

  • Prepare fresh lysates for each experiment, as GRIP domain proteins may degrade during storage

Data analysis recommendations:

  • Perform densitometry analysis using ImageJ or similar software

  • Always normalize SPAC27D7.02c signals to loading controls

  • Include biological replicates (n≥3) for statistical validation

  • Consider differences in protein expression across growth phases and stresses

How can discrepancies between immunofluorescence and biochemical data for SPAC27D7.02c be reconciled?

Discrepancies between immunofluorescence and biochemical data for SPAC27D7.02c may arise due to several factors:

Common discrepancies and resolution strategies:

  • Different subcellular localization patterns vs. biochemical fractionation results:

    • Perform sequential cell fractionation with increasing detergent strengths

    • Use both N- and C-terminal tagged versions of SPAC27D7.02c to rule out tag interference

    • Compare live-cell imaging with fixed-cell immunofluorescence

    • Isolate Golgi fractions using density gradient centrifugation and analyze SPAC27D7.02c distribution

  • Protein abundance differences between methods:

    • Quantify absolute protein levels using quantitative Western blot with recombinant standards

    • Perform flow cytometry to measure cellular heterogeneity in protein expression

    • Use single-molecule detection methods to establish detection thresholds

  • Protein modification detection discrepancies:

    • Employ phospho-specific antibodies if phosphorylation is suspected

    • Use 2D gel electrophoresis to separate protein isoforms

    • Apply mass spectrometry to identify post-translational modifications

Integrative analysis approach:

  • Create a composite model incorporating data from multiple techniques

  • Use statistical methods to weight evidence from different experimental approaches

  • Consider dynamic changes in protein localization during cell cycle or stress responses

  • Compare results with other GRIP domain proteins in S. pombe to identify conserved patterns

How can SPAC27D7.02c antibody be used to investigate Golgi dynamics during the S. pombe cell cycle?

Investigating Golgi dynamics during the S. pombe cell cycle using SPAC27D7.02c antibody requires sophisticated experimental design:

Synchronization and time-course analysis:

  • Synchronize S. pombe cells using cdc25-22 temperature-sensitive mutants or nitrogen starvation/release

  • Collect samples at regular intervals (every 20 minutes through a 3-4 hour cycle)

  • Perform dual immunofluorescence with SPAC27D7.02c antibody and cell cycle markers

  • Quantify changes in Golgi morphology, number, and distribution

Live-cell imaging complemented with fixed-cell analysis:

  • Create strains expressing fluorescently-tagged cell cycle markers

  • Perform time-lapse imaging with fixed timepoints for antibody staining

  • Analyze correlation between cell cycle stage and SPAC27D7.02c localization/abundance

Cell cycle-specific protein interactions:

  • Synchronize cells and collect at specific cell cycle stages

  • Perform immunoprecipitation with SPAC27D7.02c antibody

  • Identify cycle-specific interaction partners by mass spectrometry

  • Validate interactions with candidate proteins using proximity ligation assays

Analysis framework:

  • Quantify Golgi fragmentation/assembly using automated image analysis

  • Correlate SPAC27D7.02c distribution with microtubule organization

  • Compare Golgi inheritance patterns between mother and daughter cells

  • Investigate dependency on cell polarity pathways

This approach will reveal how GRIP domain proteins like SPAC27D7.02c contribute to Golgi reorganization throughout the cell cycle in S. pombe .

What experimental strategies can be used to explore the role of SPAC27D7.02c in response to nutrient stress in S. pombe?

To explore SPAC27D7.02c's role in nutrient stress response in S. pombe, the following experimental strategies can be implemented:

Nutrient limitation studies:

  • Subject cells to defined media with varying nitrogen sources (ammonium, glutamate, proline)

  • Monitor SPAC27D7.02c localization, abundance, and modification state using the antibody

  • Compare results between rich medium (YES) and minimal medium (EMM) conditions

  • Analyze protein half-life under different nutrient conditions using cycloheximide chase assays

TOR pathway manipulation:

  • Treat cells with Torin1 to inhibit both TORC1 and TORC2

  • Analyze changes in SPAC27D7.02c expression and localization

  • Perform co-immunoprecipitation experiments to identify stress-specific interaction partners

  • Create genetic interaction maps between SPAC27D7.02c and TOR pathway components

Experimental design table:

Nutrient ConditionAnalysis MethodKey ParametersControls
Nitrogen starvationWestern blotProtein levels, mobility shiftsWild-type vs. SPAC27D7.02c deletion
Carbon limitationImmunofluorescenceLocalization changesCo-staining with Golgi markers
Torin1 treatmentProteomicsInteraction partnersDMSO-treated controls
Amino acid starvationqPCRTranscriptional responseMultiple housekeeping genes

Data integration:

  • Correlate SPAC27D7.02c behavior with known stress response markers

  • Compare results with global studies of nutrient-responsive genes

  • Develop a model for how GRIP domain proteins participate in membrane reorganization during stress

This approach will reveal potential roles of SPAC27D7.02c in adapting membrane trafficking pathways during nutrient fluctuations, which is a critical adaptive response in yeast .

How can proteomics approaches be integrated with SPAC27D7.02c antibody-based studies to understand its broader functional context?

Integrating proteomics with SPAC27D7.02c antibody-based studies provides a comprehensive view of this protein's functional context:

Antibody-facilitated proteomics approaches:

  • Immunoprecipitation-Mass Spectrometry (IP-MS):

    • Perform IP using SPAC27D7.02c antibody under various conditions

    • Analyze precipitated proteins using LC-MS/MS

    • Apply label-free quantification to determine relative abundances

    • Use SAINT algorithm to score high-confidence interactions

  • Proximity-dependent biotinylation:

    • Create SPAC27D7.02c-BioID fusion protein

    • Identify proteins in close proximity during different cellular states

    • Validate key interactions using co-IP with SPAC27D7.02c antibody

  • Global proteome changes in SPAC27D7.02c mutants:

    • Compare proteomes of wild-type and SPAC27D7.02c deletion strains

    • Use SILAC or TMT labeling for accurate quantification

    • Focus on Golgi and vesicular trafficking pathway components

Integration strategies:

  • Network analysis:

    • Build interaction networks using Cytoscape or similar tools

    • Incorporate data from global S. pombe protein interaction studies

    • Identify functionally related protein clusters

  • Subcellular proteome correlation:

    • Correlate SPAC27D7.02c localization data with subcellular proteomics

    • Map changes in organelle composition in response to SPAC27D7.02c manipulation

  • Multi-omics data integration:

    • Combine proteomics data with transcriptomics studies

    • Integrate with phosphoproteomics to identify regulatory pathways

    • Create predictive models of SPAC27D7.02c function in cellular processes

Example workflow:

  • Identify core SPAC27D7.02c interactors by IP-MS

  • Map these interactors to cellular pathways

  • Perform targeted proteomics (MRM/PRM) to quantify pathway components

  • Validate key findings using SPAC27D7.02c antibody in orthogonal assays

This integrated approach will position SPAC27D7.02c within its functional context and reveal its role in broader cellular processes .

What controls are essential when using SPAC27D7.02c antibody in chromatin immunoprecipitation (ChIP) experiments?

When using SPAC27D7.02c antibody for ChIP experiments in S. pombe, several essential controls must be included:

Critical experimental controls:

  • Genetic controls:

    • SPAC27D7.02c deletion strain as negative control

    • Epitope-tagged SPAC27D7.02c strain for parallel ChIP using anti-tag antibody

    • Overexpression strain to validate signal enrichment

  • Antibody specificity controls:

    • Pre-immune serum or isotype-matched IgG

    • Peptide competition assay (pre-incubation with immunizing peptide)

    • Sequential ChIP with another antibody against a known interactor

  • Technical controls:

    • Input chromatin (pre-immunoprecipitation sample)

    • No-antibody control

    • Non-crosslinked sample control

    • Mock IP with unrelated antibody

  • Positive and negative genomic regions:

    • Amplify known Golgi-associated gene promoters as potential positive regions

    • Amplify heterochromatic regions as likely negative controls

    • Include telomeric regions as background controls

Validation approaches:

  • Perform ChIP-seq followed by peak calling analysis

  • Validate unexpected chromatin associations with orthogonal methods

  • Compare binding profiles with transcription factors known to regulate membrane trafficking

  • Investigate cell cycle-dependent chromatin associations

While GRIP domain proteins are typically not associated with chromatin, this approach allows rigorous testing of any potential nuclear functions of SPAC27D7.02c that might be revealed through antibody-based experiments .

How should researchers adapt immunoprecipitation protocols for studying post-translational modifications of SPAC27D7.02c?

Adapting immunoprecipitation protocols to study post-translational modifications (PTMs) of SPAC27D7.02c requires careful consideration of preservation, enrichment, and detection methods:

Protocol adaptations for PTM analysis:

  • Lysis buffer modifications:

    • Include phosphatase inhibitors (50 mM NaF, 10 mM Na₃VO₄, 60 mM β-glycerophosphate)

    • Add deubiquitinase inhibitors (PR-619, 20 mM N-ethylmaleimide)

    • Incorporate HDAC inhibitors (sodium butyrate, trichostatin A) for acetylation studies

    • Use mild detergents (0.5% NP-40) to preserve protein complexes

  • Specific PTM enrichment strategies:

    • For phosphorylation: Include phospho-peptide enrichment (TiO₂, IMAC)

    • For ubiquitination: Use tandem ubiquitin binding entities (TUBEs)

    • For SUMOylation: Employ SUMO-trap technology

  • Detection methods:

    • Immunoblotting with modification-specific antibodies

    • Mass spectrometry with neutral loss scanning for phosphorylation

    • Parallel reaction monitoring (PRM) for targeted PTM quantification

Experimental workflow:

PTM TypeBuffer AdditiveEnrichment StrategyDetection Method
PhosphorylationPhosphatase inhibitorsPhos-tag gelsMS/MS with neutral loss
UbiquitinationDUB inhibitorsK-ε-GG antibodyUbiquitin remnant profiling
AcetylationHDAC inhibitorsAnti-acetyllysine antibodyAcetylome analysis
MethylationMethyltransferase inhibitorsAnti-methyllysine antibodyMethylome profiling

Validation approaches:

  • Create phospho-mimetic and phospho-dead mutants of key residues

  • Use CRISPR to introduce PTM-blocking mutations at endogenous loci

  • Compare PTM profiles under different cellular conditions

  • Analyze the impact of PTMs on SPAC27D7.02c localization and function

This comprehensive approach will reveal how post-translational modifications regulate SPAC27D7.02c function in various cellular contexts .

How can CRISPR/Cas9 genome editing be combined with SPAC27D7.02c antibody validation for functional studies?

Combining CRISPR/Cas9 genome editing with SPAC27D7.02c antibody validation enables sophisticated functional studies:

Integrated experimental approach:

  • CRISPR/Cas9 modification strategies:

    • Generate clean gene deletions to create negative controls for antibody specificity

    • Introduce point mutations in functional domains to study specific protein features

    • Create endogenous fluorescent protein fusions for correlative microscopy

    • Engineer auxin-inducible degron tags for rapid protein depletion

  • Antibody validation in edited strains:

    • Confirm absence of signal in deletion strains

    • Validate epitope accessibility in tagged strains

    • Verify domain-specific antibody recognition in truncation mutants

    • Assess quantitative correlation between fluorescent tags and antibody signals

  • Functional dissection workflow:

    • Map GRIP domain mutations and correlate with localization/function

    • Create domain swap chimeras with other GRIP proteins

    • Engineer separation-of-function mutations

    • Develop rapid protein degradation systems for acute phenotypic analysis

Example experimental design:

Genetic ModificationAntibody ApplicationExpected OutcomeControl
Complete gene deletionWestern blot/IFNo signalWild-type strain
C-terminal point mutationsWestern blotAltered mobilityWild-type protein
GRIP domain deletionImmunofluorescenceMislocalizationFull-length protein
Endogenous GFP fusionCo-localizationSignal overlapUntagged strain

Advanced applications:

  • Create a library of domain-specific mutants for structure-function analysis

  • Perform genetic interaction screens in CRISPR-modified backgrounds

  • Develop conditional alleles for temperature-sensitive phenotypes

  • Implement optogenetic control of SPAC27D7.02c localization

This integrated approach allows researchers to fully validate antibody specificity while simultaneously gaining mechanistic insights into SPAC27D7.02c function .

What strategies can researchers use to study SPAC27D7.02c in the context of S. pombe cellular stress responses?

To study SPAC27D7.02c in the context of S. pombe stress responses, researchers can implement these comprehensive strategies:

Stress induction and analysis approaches:

  • Environmental stress panel:

    • Oxidative stress (H₂O₂, menadione)

    • Heat shock (42°C for 15-30 minutes)

    • Osmotic stress (1M sorbitol or 0.6M KCl)

    • DNA damage (UV, MMS, or phleomycin)

    • ER stress (DTT or tunicamycin)

  • Temporal analysis framework:

    • Acute response (5-30 minutes after stress)

    • Adaptation phase (1-3 hours)

    • Recovery period (post-stress removal)

    • Preconditioning experiments (mild followed by severe stress)

  • Multi-level analysis:

    • Protein abundance by quantitative Western blotting

    • Subcellular relocalization by immunofluorescence

    • Post-translational modifications via IP-MS

    • Altered protein interactions through comparative Co-IP

    • Transcriptional regulation using RT-qPCR

Experimental design matrix:

Stress TypePrimary AssaysSecondary ValidationControl Conditions
OxidativeWestern blot, localizationPhosphorylation analysisSty1 pathway activity
NutritionalCo-IP, abundanceGolgi morphology changesTOR pathway inhibition
ThermalProtein solubilityChaperone interactionsHeat shock response markers
Cell wallSecretion assaysGlycosylation analysisCell wall integrity pathway

Integrated data analysis:

  • Compare SPAC27D7.02c responses across stress types

  • Identify common regulatory mechanisms

  • Correlate with global stress response datasets

  • Map to specific stress response pathways

This systematic approach will reveal how SPAC27D7.02c participates in cellular adaptation to diverse stresses, potentially uncovering novel functions beyond its predicted Golgi-related activities .

How can researchers develop and validate phospho-specific antibodies for SPAC27D7.02c to study its regulation?

Developing and validating phospho-specific antibodies for SPAC27D7.02c requires a systematic approach:

Development strategy:

  • Phosphorylation site identification:

    • Perform phosphoproteomics analysis of S. pombe cells

    • Analyze SPAC27D7.02c sequence for predicted kinase motifs

    • Compare with phosphorylation sites in homologous proteins

    • Focus on evolutionary conserved residues within functional domains

  • Antibody generation approach:

    • Design phosphopeptide antigens (10-15 amino acids with phosphorylated residue centrally positioned)

    • Consider both polyclonal and monoclonal antibody production

    • Develop multiple antibodies against different phospho-sites

    • Use non-phosphorylated peptides for negative selection

  • Purification strategy:

    • Employ tandem affinity purification with phospho-peptide columns

    • Remove non-phospho-specific antibodies

    • Positively select with phospho-peptides

    • Perform ELISA-based titration to determine specificity

Validation framework:

Validation MethodPurposeExpected ResultControl
Western blotBasic specificitySignal in wild-type, absent in phospho-mutantLambda phosphatase treatment
Peptide competitionEpitope specificitySignal blocked by phospho-peptideNon-phospho-peptide control
ImmunofluorescenceSpatial detectionChanged localization after kinase activationPhospho-mutant strain
Kinase manipulationFunctional validationIncreased signal after kinase activationKinase inhibition

Application examples:

  • Track phosphorylation dynamics during cell cycle progression

  • Study phosphorylation changes during Golgi fragmentation and reassembly

  • Investigate kinase-dependent regulation of SPAC27D7.02c function

  • Map phosphorylation-dependent protein interactions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.